| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 06/12/2023 | 14:20 | Dow Jones News | Trending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials | USOTC:MKKGY | Merck KGaA (PK) |
| 06/12/2023 | 11:14 | Dow Jones News | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials | USOTC:MKKGY | Merck KGaA (PK) |
| 06/12/2023 | 07:37 | Dow Jones News | Merck MS Drug Fails to Meet Target of Late-Stage Trials | USOTC:MKKGY | Merck KGaA (PK) |
| 04/12/2023 | 15:09 | Dow Jones News | Merck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor Drug | USOTC:MKKGY | Merck KGaA (PK) |
| 09/11/2023 | 07:54 | Dow Jones News | Merck KGaA Sees Earnings, Sales at Lower Half of Outlook Ranges | USOTC:MKKGY | Merck KGaA (PK) |
| 06/11/2023 | 12:20 | Dow Jones News | Merck KGaA Weighs Job Cuts at Electronics Division on Market Downturn | USOTC:MKKGY | Merck KGaA (PK) |
| 30/10/2023 | 09:59 | Dow Jones News | Merck KGaA Enters Partnership With China's Hengrui for Up to $1.5 Billion | USOTC:MKKGY | Merck KGaA (PK) |
| 19/10/2023 | 10:22 | Dow Jones News | Merck KGaA Shares Jump on Expected Return to Sales Growth in 2024 | USOTC:MKKGY | Merck KGaA (PK) |
| 19/10/2023 | 08:50 | Dow Jones News | Merck KGaA Sees Return to Organic Sales Growth Next Year | USOTC:MKKGY | Merck KGaA (PK) |
| 20/09/2023 | 12:47 | Dow Jones News | Exscientia Shares Rally Premarket on Lucrative Merck Deal | USOTC:MKKGY | Merck KGaA (PK) |
| 20/09/2023 | 08:05 | Dow Jones News | Merck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug Discovery | USOTC:MKKGY | Merck KGaA (PK) |
| 03/08/2023 | 07:55 | Dow Jones News | Merck KGaA Cuts 2023 Outlook on Inventory, Semiconductor Woes | USOTC:MKKGY | Merck KGaA (PK) |
| 11/05/2023 | 07:46 | Dow Jones News | Merck KgaA 1Q Earnings Hit by Lower Covid-19 Demand, Decline at Display Solutions | USOTC:MKKGY | Merck KGaA (PK) |
| 08/05/2023 | 13:49 | Dow Jones News | Merck KGaA Appoints Helene von Roeder as New CFO | USOTC:MKKGY | Merck KGaA (PK) |
| 13/04/2023 | 15:41 | Dow Jones News | Merck KGaA Planning Sale of Surface Solutions Business, WirtschaftsWoche Reports | USOTC:MKKGY | Merck KGaA (PK) |
| 12/04/2023 | 12:51 | Dow Jones News | Merck KGaA to Invest $327 Million in Pennsylvania Site Expansion | USOTC:MKKGY | Merck KGaA (PK) |
| 12/04/2023 | 09:54 | Dow Jones News | Merck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug Trial | USOTC:MKKGY | Merck KGaA (PK) |
| 02/03/2023 | 10:50 | Dow Jones News | Merck KGaA Shares Fall After Warning of Challenges Ahead | USOTC:MKKGY | Merck KGaA (PK) |
| 02/03/2023 | 07:44 | Dow Jones News | Merck KGaA Sees Challenging 2023 After Rises in 2022 Earnings, Sales | USOTC:MKKGY | Merck KGaA (PK) |
| 22/11/2022 | 01:18 | Dow Jones News | ADRs End Mostly Lower, Naspers and Merck Trade Actively | USOTC:MKKGY | Merck KGaA (PK) |
| 21/11/2022 | 14:03 | Dow Jones News | Merck KGaA Says It Plans One New Drug Launch Every One and a Half Years | USOTC:MKKGY | Merck KGaA (PK) |
| 10/11/2022 | 08:04 | Dow Jones News | Merck KGaA 3Q Sales, Earnings Rose; Fine-Tunes 2022 Outlook | USOTC:MKKGY | Merck KGaA (PK) |
| 19/10/2022 | 15:58 | Dow Jones News | Merck KGaA's French Subsidiary Indicted in France Over Drug Formulation Change | USOTC:MKKGY | Merck KGaA (PK) |
| 19/10/2022 | 11:32 | Dow Jones News | Merck KGaA's French Unit Under Further Investigations, AFP Reports | USOTC:MKKGY | Merck KGaA (PK) |
| 06/10/2022 | 08:55 | Dow Jones News | Merck KGaA Backs Mid-Term Targets; Plans Acquisitions as of 2023 | USOTC:MKKGY | Merck KGaA (PK) |
| 04/08/2022 | 08:06 | Dow Jones News | Merck KGaA Earnings, Sales Grew in 2Q | USOTC:MKKGY | Merck KGaA (PK) |
| 03/06/2022 | 16:21 | Dow Jones News | Merck KGaA Discontinues Phase 2 Trial of Berzosertib in Combination With Topotecan | USOTC:MKKGY | Merck KGaA (PK) |
| 02/06/2022 | 18:38 | Dow Jones News | Proxygen Teams With Merck KGaA to Develop Molecular Glue Degraders | USOTC:MKKGY | Merck KGaA (PK) |
| 23/05/2022 | 11:53 | Dow Jones News | Merck KGaA to Invest Around $465 Million to Expand Operations in Ireland | USOTC:MKKGY | Merck KGaA (PK) |
| 12/05/2022 | 07:31 | Dow Jones News | Merck KGaA Expects Higher Profitability, Sales in 2022 After 1Q Earnings Rise | USOTC:MKKGY | Merck KGaA (PK) |